Organochlorines and endometrial cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 5, 2000, Pages 487-493

  Weiderpass, Elisabete ^a   Adami, Hans Olov ^a,b   Baron, John A ^c   Wicklund Glynn, Anders ^d,e   Aune, Marie ^d   Atuma, Samuel ^d   Persson, Ingemar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d NATIONAL FOOD ADMINISTRATION   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA HEXACHLOROCYCLOHEXANE; CHLORPHENOTANE; HEXACHLOROBENZENE; NONACHLOR; ORGANOCHLORINE DERIVATIVE; OXYCHLORDANE; POLYCHLORINATED BIPHENYL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST; CANCER RISK; CARCINOGENICITY; CASE CONTROL STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; ESTROGEN ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POLLUTANT; PRIORITY JOURNAL; QUESTIONNAIRE; SWEDEN;

AGED; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FASTING; FEMALE; HUMANS; HYDROCARBONS, CHLORINATED; INSECTICIDES; MIDDLE AGED; RISK FACTORS; SWEDEN;

EID: 0034108453     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Safe, S. H. Xenoestrogens and breast cancer. N. Engl. J. Med., 337: 1303-1304, 1997.
2. Wassermann, M., Nogueira, D. P., Tomatis, L., Mirra, A. P., Shibata, H., Arie, G., Cucos, S., and Wassermann, D. Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull. Environ. Contam. Toxicol., 15: 478-484, 1976.
3. Mussalo-Rauhamaa, H., Hasanen, E., Pyysalo, H., Antervo, K., Kauppila, R., and Pantzar, P. Occurrence of β-hexachlorocyclohexane in breast cancer patients. Cancer (Phila.), 66: 2124-2128, 1990.
4. Falck, F., Jr., Ricci, A., Jr., Wolff, M. S., Godbold, J., and Deckers, P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch. Environ. Health. 47: 143-146, 1992.
5. Wolff, M. S., Toniolo, P. G., Lee, E. W., Rivera, M., and Dubin, N. Blood levels of organochlorine residues and risk of breast cancer. J. Natl. Cancer Inst., 85: 648-652, 1993.
6. Dewailly, E., Dodin, S., Verreault, R., Ayotte, P., Sauve, L., Morin, J., and Brisson J. High organochlorine body burden in women with estrogen receptor positive breast cancer. J. Natl. Cancer Inst., 86: 232-234, 1994.
7. Guttes, S., Failing, K., Neumann, K., Kleinstein, J., Georgii, S., and Brunn, H. Chlororganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease. Arch. Environ. Contam. Toxicol., 35: 140-147, 1998.
8. Hunter, D. J., Hankinson, S. E., Laden, F., Colditz, G. A., Manson, J. E., Willet, W. C., Speizer, F. E., and Wolff, M. S. Plasma organochlorine levels and the risk of breast cancer. N. Engl. J. Med., 337: 1253-1258, 1997.
9. Krieger, N., Wolff, M. S., Hiatt, R. A., Rivera, M., Vogelman, J., and Orentreich, N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J. Natl. Cancer Inst., 86: 589-599, 1994.
10. Lopez-Carrillo, L., Blair, A., Lopez-Cervantes, M., Cebrian, M., Rueda, C., Reyes, R., Mohar, A., and Bravo, J. Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res., 57: 3728-3732, 1997.
11. van't Veer, P., Lobbezzoo, I. E., Martin-Moreno, J. M., Guallar, E., Gomez-Aracena, J., Kardinaal, A. F., Kohlmeier, L., Martin, B. C., Strain, J. J., Thamm, M., van Zoonen, P., Baumann, B. A., Huttunen, J. K., and Kok F. J. DDT (dicophane), and postmenopausal breast cancer in Europe: case-control study. Br. Med. J., 315: 81-85, 1997.
12. Moysich, K. B., Ambrosone, C. B., Vena, J. E., Shields, P. G., Mendola, P., Kostyniak, P., Greizerstein, H., Graham, S., Marshall, J. R., Schisterman, E. F., and Freudenheim, J. L. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol. Biomark. Prev., 7. 181-188, 1998.
13. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 350: 1047-1059, 1997.
14. Grady, D., Gebretsadik, T., Kerlikowske, K., Ernster, V., and Petitti, D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol., 85: 304-313, 1995.
15. Sturgeon, S. R., Brock, J. W., Potischman, N., Needham, L. L., Rothman, N., Brinton, L. A., and Hoover, R. N. Serum concentrations of organochlorine compounds and endometrial cancer risk (United States). Cancer Causes Control, 9: 417-424, 1998.
16. The National Board of Health and Welfare. Centre for Epidemiology. Statistics-Health and Diseases. Cancer Incidence in Sweden 1995, 107 pp. Stockholm. Sweden: National Board of Health and Welfare, 1998.
17. Atuma, S. S., and Aune, M. Method for the determination of PCB congeners and chlorinated pesticides in human serum. Bull. Environ. Contam. Toxicol., 62: 8-15, 1999.
18. Hunter, D. J., Laden, F., and Wolff, M. S. Reply in correspondence. N. Engl. J. Med., 338: 991, 1998.
19. Ahlborg, U. G., Lipworth, L., Titus-Ernstoff, L., Hsieh, C-C., Hanberg, A., Baron, J., Trichopoulos, D., and Adami, H-O. Organochlorine compounds in relation to breast cancer, endometrial cancer and endometriosis: an assessment of the biological and epidemiological evidence. Crit. Rev. Toxicol., 25: 463-531, 1995.
20. Shekar, P. V. M., Werdell, J., and Basrur, V. S. Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines. J. Natl. Cancer Inst., 89: 1774-1782, 1997.
21. Loeber, J. G., and van Helsen, F. L. Uterotrophic effects of the β-HCH, a food-chain contaminant. Food Addit. Contam., 1: 63-66, 1984.
22. Bigsby, R. M., Caperell-Grant, A., and Madhukar, B. V. Xenobiotics released from fat during fasting produce estrogenic effects in ovariectomized mice. Cancer Res., 57: 865-869, 1997.
23. Cooper, R. L., Chadwick, R. W., Rehnberg, G. L., Goldman, J. M., Booth, K. C., Hein, J. F., and McElroy, W. K. Effect of lindane on hormonal control of reproductive function in the female rat. Toxicol. Appl. Pharmacol., 99: 384-394, 1989.
24. Wedig, H., and Vernon, L. G. Can increased hepatic estrogen metabolism interfere with ovulation in the rat? Effects of chronic phenobarbital or chlordane exposure. Proc. Soc. Exp. Biol. Med., 144: 796-801, 1973.
25. Cassidy, R. A., Vorhees, C. V., Minnema, D. J., and Hastings, L. The effects of chlordane exposure during pre-and postnatal periods at environmentally relevant levels on sex steroid-mediated behaviors and functions in the rat. Toxicol. Appl. Pharmacol., 126: 326-337, 1994.
26. Ecobichon, D. J., and Mackenzie, D. O. The uterotropic activity of commercial and isomerically-pure chlorobiphenyls in the rat. Res. Commun. Chem. Pathol. Pharmacol., 9: 85-95, 1974.
27. Jansen, H. T., Cooke, P. S., Porcelli, J., Liu, T. C., and Hansen, L. G. Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod. Toxicol., 7: 237-248, 1993.
28. Soontornchat, S., Li, M. H., Cooke, P. S., and Hansen, L. G. Toxicokinetic and toxicodynamic influences on endocrine disruption by polychlorinated biphenyls. Environ. Health Perspect., 102: 568-571, 1994.
29. Waller, C. L., Minor, D. L., and McKinney, J. D. Using three-dimensional quantitative structure-activity relationships to examine estrogen receptor binding affinities of polychlorinated biphenyls. Environ. Health Perspect., 103: 702-707, 1995.
30. Wolff, M. S., Camann, D., Gammon, M., and Stellman, S. D. Proposed PCB congener grouping for epidemiological studies. Environ. Health Perspect., 105: 13-14, 1997.
31. Patnode, K. A., and Curtis, L. R. 2,2′,4,4′,5,5′-and 3,3′,4,4′,5,5′-Hexachlorobiphenyl alteration of uterine progesterone and estrogen receptors coincides with embryotoxicity in mink (Mustela vision). Toxicol. Appl. Pharmacol., 127: 9-18, 1994.
32. Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., and Wilson, E. M. Persistent DDT metabolite p.p′-DDE is a potent androgen receptor antagonist. Nature (Lond.), 375: 581-585, 1995.
33. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research. I. The Analysis of Case-Control Studies. 1ARC Publ. No. 32, pp. 5-338. Lyon, France: IARC, 1980.
34. Stenbeck, M., Rosen, M., and Holm, L. E. Cancer survival in Sweden during three decades, 1961-1991. Acta Oncol., 34: 881-891, 1995.
35. vom Saal, F. S., Welshons, W. V., and Hansen, L. G. Organochlorine residues and breast cancer. N. Engl. J. Med., 337: 988, 1998.
36. Hoyer, A. P., Grandjean, P., Jorgensen, T., Brock, J. W., and Hartvig, H. B. Organochlorine exposure and risk of breast cancer. Lancet. 352: 1816-1820, 1998
37. Lundén, Å., and Norén, K. Polychlorinated naphthalenes and other Organochlorine contaminants in Swedish human milk, 1972-1992. Arch. Environ. Contam. Toxicol., 34: 414-423, 1998.
38. Atuma, S., Hansson, L., Johnsson, H., Slorach, S., de Wit, C. A., and Lindström, G. Organochlorine pesticides, polychlorinated biphenyls and dioxins in human milk from Swedish mothers. Food Addit. Contam., 15: 142-150, 1998.
39. Hovinga, M. E., Sowers, M. F., and Humphrey, H. E. Historical changes in serum PCB and DDT levels in an environmentally-exposed cohort. Arch. Environ. Contam. Toxicol., 22: 362-366, 1992.
40. Ekbom, A., Wicklund-Glynn, A., and Adami. H-O. DDT and testicular cancer. Lancet, 347: 553-554, 1996.